RNA interference mediated inhibition of BCL2 gene expression using short interfering nucleic acid (siNA)

Details for Australian Patent Application No. 2003213119 (hide)

Owner SIRNA THERAPEUTICS, INC.

Inventors Beigelman, Leonid; McSwiggen, James

Agent Spruson & Ferguson

Pub. Number AU-A-2003213119

PCT Number PCT/US03/04908

PCT Pub. Number WO2003/070969

Priority 60/386,782 06.06.02 US; 60/396,905 18.07.02 US; 60/406,784 29.08.02 US; 60/408,378 05.09.02 US; 60/409,293 09.09.02 US; 60/440,129 15.01.03 US; 60/358,580 20.02.02 US; 60/363,124 11.03.02 US

Filing date 18 February 2003

Wipo publication date 9 September 2003

Event Publications

24 July 2003 Complete Application Filed

  Priority application(s): 60/386,782 06.06.02 US; 60/396,905 18.07.02 US; 60/406,784 29.08.02 US; 60/408,378 05.09.02 US; 60/409,293 09.09.02 US; 60/440,129 15.01.03 US; 60/358,580 20.02.02 US; 60/363,124 11.03.02 US

9 October 2003 Application Open to Public Inspection

  Published as AU-A-2003213119

11 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003213120-HUMAN RNASE III AND COMPOSITIONS AND USES THEREOF

2003213118-FUSION PROTEINS OF MYCOBACTERIUM TUBERCULOSIS